Diaceutics (LON:DXRX) CFO, Nick Roberts & CIO Ryan Keeling present full year results for the period ended 31 December 2022, which shows a strong trading performance with continued momentum driving strategic investment into 2023.

Watch the video here.

Listen to the podcast here.

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here